Skip to content
Home/Companies/Biotech/Akamis Bio
AB

Akamis Bio

Biotech·UK·Exited 2026·Held 11yr

Akamis Bio is a biotech company, headquartered in UK.

Entry
2015
Hold
11yr
Exit
2026
Est. EV
–

Who owns Akamis Bio?

Akamis Bio was owned by Mercia Asset Management through Mercia Direct Investments (2014 vintage) from 2015 to 2026, exited via Trade Sale.

Hand-verified · updated 2026-07-08

Mercia Asset Management
Investor
Mercia Asset Management
Mercia Direct Investments · 2014 · Balance Sheet

Key facts

HQUK
SectorBiotech
StatusAcquired
Exit Type
Trade Sale
Buyer
–
MOIC
–
Exit Year
2026

More from Mercia Direct Investments

Other portfolio companies in the same fund.

Aonic
Active
SoftwareSweden· 2023
Axis Spine Technologies
Active
MedTechUK· 2022
Netacea
Active
CybersecurityUK· 2022
Nova Pangaea
Active
ClimateTechUK· 2022
Forensic Analytics
Active
SoftwareUK· 2021
Locate Bio
Active
BiotechUK· 2021

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
Data refreshed weekly · Sourced from public filings